NCT06203145View on ClinicalTrials.gov

A Clinical Study on the Whole-course Management (BCD-KPD-AutoHSCT) Scheme for Patients With RIMM

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 2, 2024

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2025

Conditions
Multiple MyelomaRenal Injury
Interventions
DRUG

Bortezomib

A reduction in serum FLCs level of more than 80% by day 14 of BCD is defined BCD-AutoHSCT group; A reduction in serum FLCs level of less than 80% by day 14 of BCD is defined BCD-KPD-AutoHSCT group.

Trial Locations (1)

100034

RECRUITING

Peking University First Hospital, Beijing

All Listed Sponsors
lead

Peking University First Hospital

OTHER